Can a Selection-Centric, Strengths-Based Approach to Cancer Treatment Help Treat or Prevent Cancer and Metastatic Disease?

Dr. Bruce Gottlieb is the Project Director of the Lady Davis Institute for Medical Research at the Jewish General Hospital and Adjunct Professor of the Department of Human Genetics & Ingram School of Nursing at the McGill University in Montreal, Canada. This article belongs to one of his conferences and is an expanded abstract of his talk, to which he has added the most important references that he used at the conference. The approach of almost all current cancer therapies is essentially the same as those practiced by the Greeks and Romans, namely, to remove cancer tissues at a stage early enough to prevent cancer from overwhelming the body. While initial treatment regimens are often based on specific genomic data and are effective in many cases, they can sometimes be followed, usually after a period, by the reoccurrence of cancer as untreatable metastatic disease1, often with poor prognoses due to treatment resistance2.